Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome

Abstract Background Despite strong antiplatelet therapy with ticagrelor, serious ischemic events still occur in patients with acute coronary syndrome (ACS). The predictability of platelet reactivity to the residual risk of ischemic events during ticagrelor treatment remains uncertain. Objectives We...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Yuting Zou, Yuyan Wang, Yangxun Wu, Shizhao Zhang, Haiping Liu, Tong Yin
Format: Artigo
Jezik:Inglês
Izdano: BMC 2022-04-01
Serija:Thrombosis Journal
Teme:
Ticagrelor
Platelet inhibition rate
Thromboelastography
Acute coronary syndrome
Online dostop:https://doi.org/10.1186/s12959-022-00380-4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki